Search Results - "Youngberg, Stephen P."

Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir by Hulskotte, Ellen G. J., Feng, Hwa-Ping, Xuan, Fengjuan, van Zutven, Marga G. J. A., Treitel, Michelle A., Hughes, Eric A., O'Mara, Edward, Youngberg, Stephen P., Wagner, John A., Butterton, Joan R.

“…Background. Boceprevir represents a new treatment option for hepatitis C (HCV)—infected patients, including those with HCV/human immunodeficiency virus…”
Get full text

Bioavailability and pharmacokinetic profile of a newly-developed twice-a-day sustained-release paracetamol formulation by Liu, Dongzhou J, Collaku, Agron, Youngberg, Stephen P

“…A new twice daily sustained-release (SR) paracetamol formulation was developed to improve convenience and enhance patient compliance for treatment of pain from…”
Get full text

Fibromuscular disease of the renal arteries by Youngberg, S P, Sheps, S G, Strong, C G

Get more information

Collecting duct sodium reabsorption in deoxycorticosterone-treated rats by Haas, J A, Berndt, T J, Youngberg, S P, Knox, F G

“…In vitro studies of isolated, perfused, cortical collecting tubules have demonstrated that prior chronic deoxycorticosterone acetate (DOCA) treatment increases…”
Get full text

Management of the patient with renovascular hypertension by Youngberg, S P, Sheps, S G, Strong, C G

“…Renal artery stenosis, either fibromuscular or atheromatous, is probably the most common cause of secondary hypertension in man. Both of these diseases are…”
Get more information